Drug Patents owned by King Pharms

1. Drug name - LEVOXYL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7101569 KING PHARMS Methods of administering levothyroxine pharmaceutical compositions Oct, 2023

(11 months from now)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Treatment: Method of use of administering levothyroxine

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.3MG TABLET;ORAL Discontinued

2. Drug name - SKELAXIN

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7122566 KING PHARMS Metaxalone products, method of manufacture, and method of use Feb, 2026

(3 years from now)

Drugs and Companies using METAXALONE ingredient

Treatment: Treatment of musculoskeletal conditions

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
400MG TABLET;ORAL Discontinued
800MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.